These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 2389514)
1. Bromocriptine plus suboptimal cyclosporine treatment abrogates acute rejection of rat cardiac allografts. Di Stefano R; Carmellini M; Carobbi A; Vaglini F; Petrini M; Ricci F; Mosca F; Malvaldi G Transplant Proc; 1990 Aug; 22(4):2015-6. PubMed ID: 2389514 [No Abstract] [Full Text] [Related]
2. Progressive change in tolerance mechanisms after withdrawing combination immunosuppression with cyclosporine and rapamycine or leflunomide. Lin Y; Waer M Transplant Proc; 1996 Dec; 28(6):3159. PubMed ID: 8962224 [No Abstract] [Full Text] [Related]
3. Immunosuppressants suppressing signal 2 of T-cell activation enable CsA to induce operational transplantation tolerance in a strongly immunogenic heart allograft model in rats. Lin Y; Goebels J; Vandeputte M; Waer M Transplant Proc; 1996 Apr; 28(2):977-8. PubMed ID: 8623485 [No Abstract] [Full Text] [Related]
4. Cyclosporine dosage can be reduced when used in combination with an anti-intercellular adhesion molecule-1 monoclonal antibody in rats undergoing heterotopic heart transplantation. Harrison PC; Mainolfi E; Madwed JB J Heart Lung Transplant; 1998 Feb; 17(2):150-7. PubMed ID: 9513853 [TBL] [Abstract][Full Text] [Related]
5. Effect of combined administration of low dose cyclosporine A with a thromboxane synthetase inhibitor on acute cardiac allograft rejection. Sakurai Y; Kagawa K; Kato Y; Otani H; Nonoyama A Transplant Proc; 1990 Aug; 22(4):1686-8. PubMed ID: 2389433 [No Abstract] [Full Text] [Related]
6. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts. Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767 [TBL] [Abstract][Full Text] [Related]
7. Effects of combined therapy with prostaglandin E1 and cyclosporine A on rat heart allograft survival. Ozawa T; Kamada N; Ashizawa T; Aoki T; Koyanagi Y; Kimura K Transplant Proc; 1991 Aug; 23(4):2213-4. PubMed ID: 1871850 [No Abstract] [Full Text] [Related]
8. Evaluation of the use of brequinar sodium and cyclosporine combination therapy for preventing rat cardiac allograft rejection. Cosenza CA; Cramer DV; Eiras-Hreha G; Cajulis E; Wang HK; Makowka L Transplant Proc; 1993 Jun; 25(3 Suppl 2):57-8. PubMed ID: 8516945 [No Abstract] [Full Text] [Related]
9. FTY720, a novel immunosuppressant possessing unique mechanisms. II. Long-term graft survival induction in rat heterotopic cardiac allografts and synergistic effect in combination with cyclosporine A. Hoshino Y; Suzuki C; Ohtsuki M; Masubuchi Y; Amano Y; Chiba K Transplant Proc; 1996 Apr; 28(2):1060-1. PubMed ID: 8623226 [No Abstract] [Full Text] [Related]
10. Modified graft rejection by transfusion of the donor: a role for dendritic cells. Heineman E; Bouwman E; Marquet RL; Jeekel J Transplant Proc; 1987 Feb; 19(1 Pt 2):1470-2. PubMed ID: 3274358 [No Abstract] [Full Text] [Related]
11. How cyclosporine modifies histological and molecular events in the vascular wall during chronic rejection of rat cardiac allografts. Koskinen PK; Lemström KB; Häyry PJ Am J Pathol; 1995 Apr; 146(4):972-80. PubMed ID: 7536397 [TBL] [Abstract][Full Text] [Related]
12. Partial T-cell depletion with monoclonal antibody improves the enhancing effect of donor-specific transfusion plus cyclosporine. Brunson ME; Tchervenkov JI; Alexander JW; Cofer BR Transplant Proc; 1991 Feb; 23(1 Pt 1):307-8. PubMed ID: 1990538 [No Abstract] [Full Text] [Related]
13. Immunosuppressive effects of leflunomide in a cardiac allograft model. Williams JW; Xiao F; Foster PF; Chong A; Sharma S; Bartlett R; Sankary HN Transplant Proc; 1993 Feb; 25(1 Pt 1):745-6. PubMed ID: 8438465 [No Abstract] [Full Text] [Related]
14. Treatment strategies of hamster-to-rat cardiac xenotransplantation. Steinbrüchel DA; Nielsen B; Kemp E Transplant Proc; 1994 Apr; 26(2):1039-41. PubMed ID: 8171460 [No Abstract] [Full Text] [Related]
15. Effect of steroids on cellular proliferation in rat cardiac allografts. Ruers TJ; Buurman W; Kootstra G Transplant Proc; 1991 Feb; 23(1 Pt 1):488. PubMed ID: 1990594 [No Abstract] [Full Text] [Related]
16. Effect of hyperlipidemia and immunosuppressive drugs on cardiac allograft vascular disease in heterotopic rat cardiac transplantation. Hisatomi K; Isomura T; Matsuzoe S; Satou T; Hirano A; Kohjiro M Transplant Proc; 1996 Jun; 28(3):1958-60. PubMed ID: 8658960 [No Abstract] [Full Text] [Related]
17. Control and reversal of chronic xenograft rejection in hamster-to-rat cardiac transplantation. Xiao F; Shen J; Chong A; Liu W; Foster P; Blinder HL; Sankary H; McChesney L; Mital D; Williams JW Transplant Proc; 1996 Apr; 28(2):691-2. PubMed ID: 8623348 [No Abstract] [Full Text] [Related]
18. Efficacy of leflunomide in combination with current immunosuppressive agents in rat cardiac allotransplantation. Candinas D; Achilleos O; Lee SJ; Dalgic A; Mayer AD; Buckels JA; McMaster P; D'Silva M Transplant Proc; 1994 Dec; 26(6):3251-2. PubMed ID: 7527959 [No Abstract] [Full Text] [Related]
19. Unresponsiveness to rat cardiac allografts induced by intrathymic injection of donor bone marrow cells and short course of immunosuppression. Hara Y; Matsuura T; Imanishi M; Tahara H; Kurita T Transplant Proc; 1994 Dec; 26(6):3226-8. PubMed ID: 7527955 [No Abstract] [Full Text] [Related]
20. Tempo of induction of W3/25+ suppressor cells in cyclosporine-treated rat cardiac allograft recipients. Hall BM; Gurley KE; Dorsch SE Transplant Proc; 1987 Feb; 19(1 Pt 1):504. PubMed ID: 2978917 [No Abstract] [Full Text] [Related] [Next] [New Search]